MSC Tolerogenic treatments to improve long term Renal engraftment
Validate targets, mechanisms and translational rationale before committing development resources.
Offer overview
What this offer helps you achieve
Validate targets, mechanisms and translational rationale before committing development resources.
Scientific and technical scope
MSCs to treat chronic Renal Transplantation rejection developed by Antoine Dürrbach Phase : randomised translational and clinical phase I/II Allogeneic umbilical cord Mesenchymal Stem Cell for the treatment of Chronic Antibody-Mediated Rejection After Renal Transplantation - Hospital Clinical Research Program – Grant - PHRCI 21
Capabilities mobilised
Therapeutic areasTherapeutic target discovery
Application fields
Immune disorders
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
